Patents by Inventor Julien Parcq

Julien Parcq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CROSSLINKED STARCH DERIVATIVE-BASED MATRIX
    Publication number: 20230233686
    Abstract: The invention relates to a water insoluble solid crosslinked dextrin-based matrix, wherein the crosslinking agent is sodium trimetaphosphate (STMP), its use and method of preparation.
    Type: Application
    Filed: June 16, 2021
    Publication date: July 27, 2023
    Inventors: Julien PARCQ, Vincent WIATZ, Maxime INGRET
  • METHOD FOR ANNEALING PEA STARCH
    Publication number: 20220408766
    Abstract: The present invention relates to a method for preparing a legume starch with a high content of slowly digestible fraction (SDS), a hydrothermal treatment method characterized in that it comprises the following steps: 1) Preparing a starch milk with a dry matter content of between 30 and 40% by weight, preferably 32% by weight, 2) Heating the starch milk prepared in this way to a temperature 10 to 15° C. lower than its gelatinization temperature, 3) Stirring the starch milk obtained in this way at this temperature for between 45 minutes and 7 hours, preferably between 1 hour and 6 hours, 4) Recovering, filtering and drying the starch milk treated in this way.
    Type: Application
    Filed: November 19, 2020
    Publication date: December 29, 2022
    Inventors: Julien PARCQ, Alban DUPONT, Marie ALBERT, Fabrice DESAILLY
  • LOW-DIGESTIBLE LEGUME STARCH
    Publication number: 20220400715
    Abstract: The invention relates to legume starches having a slowly digestible starch (SDS) content of 30 to 34% by weight, characterized in that they also have a very slowly digestible starch (vSDS) content of 34 to 40% by weight.
    Type: Application
    Filed: November 19, 2020
    Publication date: December 22, 2022
    Inventors: Julien PARCQ, Alban DUPONT, Marie ALBERT, Fabrice DESAILLY
  • Substituted pyrrolidines as G-protein coupled receptor 43 agonists
    Patent number: 11072582
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Grant
    Filed: July 15, 2020
    Date of Patent: July 27, 2021
    Assignee: Epics Therapeutics
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS
    Publication number: 20200347016
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Application
    Filed: July 15, 2020
    Publication date: November 5, 2020
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • Substituted pyrrolidines as G-protein coupled receptor 43 agonists
    Patent number: 10781171
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: September 22, 2020
    Assignee: Epics Therapeutics
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS AS AGONISTS OF G-PROTEIN COUPLED RECEPTOR 43 (GPR43)
    Publication number: 20200148636
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 14, 2020
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • Substituted pyrrolidines as G-protein coupled receptor 43 agonists
    Patent number: 10577318
    Abstract: The present invention is directed to novel intermediates of the formula E: which are useful in the synthesis of agonists of g-protein coupled receptor 43 for treating and/or preventing metabolic diseases.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: March 3, 2020
    Assignee: Epics Therapeutics
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS
    Publication number: 20190300478
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and or preventing metabolic diseases.
    Type: Application
    Filed: June 18, 2019
    Publication date: October 3, 2019
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • Substituted pyrrolidines as G-protein coupled receptor 43 agonists
    Patent number: 10358416
    Abstract: The present invention is directed to a process for the preparation of aryl-carbonyl-pyrrolidine carboxylic acid derivative compounds which are useful in treating metabolic diseases, said process consisting of coupling a pyrrolidine ester compound with an aryl carboxylic acid derivative, followed by alkaline or acidic treatment, hydrogenolysis or treatment with a fluoride of the obtained intermediate, to afford novel aryl-carbonyl-pyrrolidine carboxylic acid derivative compounds.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: July 23, 2019
    Assignee: Epics Therapeutics
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • Dextrin copolymer with styrene and an acrylic ester, manufacturing method thereof, and use thereof for paper coating
    Patent number: 10160815
    Abstract: Disclosed is a copolymer of a dextrin and at least two hydrophobic monomers made up of styrene and at least one straight or branched acrylic C1-C4 ester. The invention also relates to the manufacturing method thereof and to the use thereof in paper coating. The copolymer has high dextrin content (>60 wt % relative to the weight of the dextrin and the hydrophobic monomers) so as to favor the biosourced aspect of the material, and provides very good hydrophobicity for the paper sheet.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: December 25, 2018
    Assignee: Roquette Freres
    Inventors: Julien Parcq, Vincent Wiatz
  • SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS
    Publication number: 20180297944
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 18, 2018
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • Substituted pyrrolidines as G-protein coupled receptor 43 agonists
    Patent number: 10017468
    Abstract: The present invention is directed to a process for the preparation of aryl-pyrrolidine carboxylic acid derivative compounds which are useful in treating metabolic diseases, said process consisting of coupling an aryl-pyrrolidine compound with an aryl carboxylic acid compound followed by alkaline or acidic treatment, hydrogenolysis or treatment with a fluoride of the ester intermediate to afford novel aryl-pyrrolidine carboxylic acid derivative compounds.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: July 10, 2018
    Assignee: Ogeda SA
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS
    Publication number: 20170283376
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Application
    Filed: June 15, 2017
    Publication date: October 5, 2017
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • DEXTRIN COPOLYMER WITH STYRENE AND AN ACRYLIC ESTER, MANUFACTURING METHOD THEREOF, AND USE THEREOF FOR PAPER COATING
    Publication number: 20170275387
    Abstract: Disclosed is a copolymer of a dextrin and at least two hydrophobic monomers made up of styrene and at least one straight or branched acrylic C1-C4 ester. The invention also relates to the manufacturing method thereof and to the use thereof in paper coating. The copolymer has high dextrin content (>60 wt % relative to the weight of the dextrin and the hydrophobic monomers) so as to favor the biosourced aspect of the material, and provides very good hydrophobicity for the paper sheet.
    Type: Application
    Filed: August 13, 2015
    Publication date: September 28, 2017
    Inventors: Julien PARCQ, Vincent WIATZ
  • Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
    Patent number: 9770435
    Abstract: Compounds of formula I are useful in treating and/or preventing inflammatory diseases.
    Type: Grant
    Filed: November 27, 2014
    Date of Patent: September 26, 2017
    Assignee: OGEDA SA
    Inventors: Hamid Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq, Jerome Bernard, Graeme Fraser
  • Substituted pyrrolidines as G-protein coupled receptor 43 agonists
    Patent number: 9695120
    Abstract: The present invention is directed to novel pyrrolidine carboxylic acid derivatives, pharmaceutical compositions, and their use in treating and/or preventing metabolic diseases as agonists of g-protein coupled receptor 43.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: July 4, 2017
    Assignee: Ogeda SA
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq
  • COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING INFLAMMATORY DISEASES
    Publication number: 20160303075
    Abstract: Compounds of formula I are useful in treating and/or preventing inflammatory diseases.
    Type: Application
    Filed: November 27, 2014
    Publication date: October 20, 2016
    Inventors: Hamid HOVEYDA, Didier SCHILS, Ludivine ZOUTE, Julien PARCQ, Jerome BERNARD, Graeme FRASER
  • METHOD FOR THE REACTIVE EXTRUSION OF AN AMYLACEOUS MATERIAL IN THE PRESENCE OF A POLYPHOSPHATE SERVING AS A CROSS-LINKING AGENT, RESULTING PRODUCTS, AND USES THEREOF
    Publication number: 20150299431
    Abstract: A method for the reactive extrusion of an amylaceous substance in the presence of a polyphosphate serving as a cross-linking agent, to the resulting products, and to the uses thereof. In particular, a method for the reactive extrusion of starch in the presence of a cross-linking agent which is a polyphosphate, in particular sodium trimetaphosphate, which behaves like an effective substitute for glyoxal. The method makes it possible to manage the competition between the destructuring and cross-linking mechanisms of the amylaceous substance. The crystalline phase content of the cross-linked starches is thus controlled in accordance with the specific needs of the final use.
    Type: Application
    Filed: July 30, 2013
    Publication date: October 22, 2015
    Inventors: Julien PARCQ, Rene SAINT-LOUP, Vincent WIATZ
  • PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS AS AGONISTS OF G-PROTEIN COUPLED RECEPTOR 43 (GPR43)
    Publication number: 20130023539
    Abstract: The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.
    Type: Application
    Filed: June 18, 2012
    Publication date: January 24, 2013
    Applicant: Euroscreen S.A.
    Inventors: Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq